0001628280-22-018050.txt : 20220627 0001628280-22-018050.hdr.sgml : 20220627 20220627161551 ACCESSION NUMBER: 0001628280-22-018050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220606 FILED AS OF DATE: 20220627 DATE AS OF CHANGE: 20220627 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stewart Murray CENTRAL INDEX KEY: 0001723450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38295 FILM NUMBER: 221044734 MAIL ADDRESS: STREET 1: C/O NOVELION THERAPEUTICS INC. STREET 2: 1800-510 WEST GEORGIA STREET CITY: VANCOUVER STATE: A1 ZIP: V6B OM3 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: X4 Pharmaceuticals, Inc CENTRAL INDEX KEY: 0001501697 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273181608 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 61 NORTH BEACON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 BUSINESS PHONE: 857-529-8300 MAIL ADDRESS: STREET 1: 61 NORTH BEACON STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02134 FORMER COMPANY: FORMER CONFORMED NAME: Arsanis, Inc. DATE OF NAME CHANGE: 20100920 4 1 wf-form4_165636093576773.xml FORM 4 X0306 4 2022-06-06 0 0001501697 X4 Pharmaceuticals, Inc XFOR 0001723450 Stewart Murray C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET, 4TH FLOOR BOSTON MA 02134 1 0 0 0 Common Stock 2022-06-06 4 A 0 6667 0 A 6667 D Represents an annual grant of restricted stock units ("RSUs") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Represents unvested RSUs. Derek M. Meisner, attorney-in-fact 2022-06-27